March 2022: Madi: On exhaustion of T cells in cancer

Dr. Asaf Madi, Edmond J. Safra affiliate, publishes a study on exhaustion of T cells in cancer.

March 2022: Madi: On exhaustion of T cells in cancer
Asaf Madi, Edmond J. Safra affiliate (Medicine), in collaboration with colleagues from Yale and Harvard, mapped the entire signaling cascade of Type 1 interferon (IFN-I) in human T cells and found regulatory mechanisms that drive the expression of co-inhibitory receptors in humans.
T cells play a key role in protecting our body from cancer. However, once those T cells are exposed to the tumor, they lose their function and become exhausted. Immune checkpoint blockade targeting T cell co-inhibitory receptors, thereby preventing exhaustion, has revolutionized cancer treatment. However, many patients still do not respond to these drugs, highlighting the importance of studying the mechanism of T cell exhaustion. The study reveals regulatory mechanisms of co-inhibitory receptor induction in human T cells by IFN-I.
The research published in Nature Immunology was featured in online newspaper DOCTORS ONLY.


Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>